PTK2 and neoplasm: Leveraging the nuclear location signal peptide and AS1411 aptamer, which has an affinity for nucleolin in tumor cell membranes and nuclei, the delivery vector specifically targets tumorous cell nuclei, knocking out the PTK2 gene to down-regulate FAK.